Dana-Farber’s Katherine Janeway, M.D., discusses how reimbursement policies for molecular diagnostics have failed to keep pace with scientific evidence, leaving gaps in the care for pediatric bone ...

ABL Diagnostics accelerates international growth with key public contracts and platform-agnostic microbiology solutions ...

DeepChek® NGS ecosystem maps viral resistance mutations to next-generation therapies, unlocking new insights for ...

The growing molecular oncology diagnostics market is fueled by rising global cancer rates and demand for personalized medicine. Opportunities lie in leveraging next-gen sequencing and liquid biopsies ...

Molecular diagnostics hold immense potential, but their precision depends on rigorous quality control, validation, and verification processes. From assay design to data management, every step impacts ...

Joint development strategy has been developed to address international deployment requirements if current outbreak continues ...

Molecular diagnostic techniques are a broad range of laboratory methods that utilise the principles of molecular biology and genetics to identify and diagnose diseases, monitor treatment responses, ...

U.S. market projected to grow from USD 1.57 billion in 2025 to USD 2.67 billion by 2035, while Europe market expected to reach USD 3.58 billion driven by expanding transplant networks and advanced ...

View Insight Molecular Diagnostics Inc. IMDX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Company to use funds raised from shareholders for capacity expansion, molecular diagnostics and clinical infrastructure ...

Insight Molecular Diagnostics now sits under a refreshed analyst narrative, with a price target that has moved to US$12 per share alongside an updated fair value estimate of US$10.50. Analysts linking ...